Need for circular use of materials in construction Construction and demolition waste are being recycled on a large scale to use as a foundation for e.g. roads, but recycled building materials are hardly ever used in the construction of buildings.
Breakthrough on cumulative risk assessment exposure to pesticides in food The European Commission, Member States and EFSA have taken a major step forward in their work on assessing the cumulative risks from exposure to pesticides in food.
Tool for risk assessment of nanomaterials in cosmetics Both regulators and manufacturers need to evaluate and manage consumer health risks that may be posed by the use of nanomaterials in cosmetics.
New possibilities for the responsible recycling of plastics RIVM proposes the consideration of a broader environmental perspective in the trade-off between incineration or recycling of plastics.
Priorities for science and society about the influence of ecosystems on well-being An international network of researchers has set new priorities for science and society in the area of ecosystems and their influence on social well-being.
Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
Greater influx of migrants not expected to lead to an increase in cases of tuberculosis According to the RIVM report ‘Tuberculosis in the Netherlands 2014’, a total of 823 people were diagnosed with TB last year. That is 21 fewer patients than in 2013.
Replacement possible for products with carcinogenic formaldehyde There seem to be sufficient alternatives available for the majority of disinfectants and preservatives containing the carcinogenic substance formaldehyde.
WHO’s first ever global estimates of foodborne diseases: children under five account for almost one third of deaths Almost one third (30%) of all deaths from foodborne diseases are in children under the age of five years, despite the fact that they make up only 9% of the global population.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.